Manage cookies

Cookies

We use cookies to collect statistics on how the visitors navigate the website and to improve the user experience. Find out more on how we use cookies and how you can change your settings. Please check our data protection policy.

Accept all cookies
Accept only essential cookies
1887
Rapid communication Open Access
Like 0

Abstract

We report the strategy leading to the first detection of variant of concern 202012/01 (VOC) in France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified in certain SARS-CoV-2 variants including VOC, is screened for. This deletion is associated with a S-gene target failure (SGTF) in the three-target RT-PCR assay (TaqPath kit). Subsequently, SGTF samples are whole genome sequenced. This approach revealed mutations co-occurring with ΔH69/ΔV70 including S:N501Y in the VOC.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.3.2100008
2021-01-21
2024-12-30
/content/10.2807/1560-7917.ES.2021.26.3.2100008
Loading
The full text of this article is not currently available.

References

  1. European Centre for Disease Prevention and Control (ECDC). ECDC to assess risk associated with spread of SARS-CoV-2 in mink farms. Stockholm: ECDC; 2020. [Accessed 8 Nov 2020]. Available from: https://www.ecdc.europa.eu/en/news-events/ecdc-assess-risk-associated-spread-sars-cov-2-mink-farms
  2. World Health Organization (WHO). SARS-CoV-2 mink-associated variant strain – Denmark. Geneva: WHO. [Accessed 25 Nov 2020]. Available from: http://www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en/
  3. Lassaunière R, Fonager J, Rasmussen M, Frische A, Polacek Strandh C, Bruun Rasmussen T, et al. Working paper on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data. Copenhagen: Statens Serum Institut. Available from: https://files.ssi.dk/Mink-cluster-5-short-report_AFO2
  4. Kemp SA, Datir RP, Collier DA, Ferreira I, Carabelli A, Harvey W, et al. Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70. bioRxiv. 2020:2020.12.14.422555; (Preprint). https://doi.org/10.1101/2020.12.14.422555
  5. Thomson EC, Rosen LE, Shepherd JG, Spreafico R, Filipe A da S, Wojcechowskyj JA, et al. The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. bioRxiv. 2020:2020.11.04.355842.(Preprint). https://doi.org/10.1101/2020.11.04.355842
  6. Andrew Rambaut, Nick Loman, Oliver Pybus, Wendy Barclay, Jeff Barrett, Alesandro Carabelli, Tom Connor, Tom Peacock, David L Robertson, Erik Volz, on behalf of COVID-19 Genomics Consortium UK (CoG-UK). Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological.org. [Accessed 21 Dec 2020]. Available from: https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563/1
  7. Bal A, Destras G, Gaymard A, Bouscambert-Duchamp M, Valette M, Escuret V, et al. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020;26(7):960-2.  https://doi.org/10.1016/j.cmi.2020.03.020  PMID: 32234449 
  8. Singer J, Gifford R, Cotten M, Robertson D. CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. 2020. doi: https://doi.org/10.20944/preprints202006.0225.v1 .
  9. Charre C, Ginevra C, Sabatier M, Regue H, Destras G, Brun S, et al. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation. Virus Evol. 2020;6(2):veaa075.  https://doi.org/10.1093/ve/veaa075  PMID: 33318859 
  10. World Health Organization (WHO). Molecular assays to diagnose COVID-19: Summary table of available protocols. Geneva: WHO; 24 January 2020. Available from: https://www.who.int/publications/m/item/molecular-assays-to-diagnose-covid-19-summary-table-of-available-protocols
  11. Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife. 2020;9:e61312.  https://doi.org/10.7554/eLife.61312  PMID: 33112236 
  12. Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 2020;369(6506):1014-8.  https://doi.org/10.1126/science.abd0831  PMID: 32540904 
  13. Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020;182(5):1295-1310.e20.  https://doi.org/10.1016/j.cell.2020.08.012  PMID: 32841599 
  14. Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv. 2020: 2020.12.30.20249034. (Preprint). https://doi.org/ https://doi.org/10.1101/2020.12.30.20249034 
  15. Kemp SA, Collier DA, Datir R, Gayed S, Jahun A, Hosmillo M, et al. Neutralising antibodies drive Spike mediated SARS-CoV-2 adaptation. medRxiv. 2020:2020.12.05.20241927. (Preprint). https://doi.org/10.1101/2020.12.05.20241927
  16. Soh WT, Liu Y, Nakayama EE, Ono C, Torii S, Nakagami H, et al. The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN. bioRxiv. 2020:2020.11.05.369264. (Preprint). doi: https://doi.org/10.1101/2020.11.05.369264
  17. Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020;369(6504):650-5.  https://doi.org/10.1126/science.abc6952  PMID: 32571838 
  18. McCarthy KR, Rennick LJ, Nambulli S, Robinson-McCarthy LR, Bain WG, Haidar G, et al. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. bioRxiv. 2020:2020.11.19.389916. (Preprint). https://doi.org/10.1101/2020.11.19.389916
  19. Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. 2020:2020.12.21.20248640. (Preprint). https://doi.org/ https://doi.org/10.1101/2020.12.21.20248640 
  20. Public Health England (PHE). Investigation of novel SARS-COV-2 variant. Variant of Concern 202012/01. London: PHE. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/947048/Technical_Briefing_VOC_SH_NJL2_SH2.pdf
/content/10.2807/1560-7917.ES.2021.26.3.2100008
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error